Edgewise Therapeutics Stock (NASDAQ: EWTX) stock price, news, charts, stock research, profile.
Open | $15.110 |
Close | $15.650 |
Volume / Avg. | 557.752K / 809.479K |
Day Range | 15.100 - 15.900 |
52 Wk Range | 5.120 - 20.690 |
Market Cap | $1.457B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 10.35% |
Days to Cover | 9.34 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Edgewise Therapeutics (NASDAQ: EWTX) through any online brokerage.
Other companies in Edgewise Therapeutics’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS), Neumora Therapeutics (NASDAQ:NMRA) and ANI Pharmaceuticals (NASDAQ:ANIP).
The latest price target for Edgewise Therapeutics (NASDAQ: EWTX) was reported by RBC Capital on Monday, April 22, 2024. The analyst firm set a price target for 32.00 expecting EWTX to rise to within 12 months (a possible 104.47% upside). 15 analyst firms have reported ratings in the last year.
The stock price for Edgewise Therapeutics (NASDAQ: EWTX) is $15.65 last updated Today at April 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Edgewise Therapeutics.
Edgewise Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Edgewise Therapeutics.
Edgewise Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.